Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Sep;46(5):848-873.
doi: 10.1002/jimd.12664.

Fifty years of research on mitochondrial fatty acid oxidation disorders: The remaining challenges

Christine Vianey-Saban  1 , Nathalie Guffon  2 , Alain Fouilhoux  2 , Cécile Acquaviva  1
Affiliations
Review

Fifty years of research on mitochondrial fatty acid oxidation disorders: The remaining challenges

Christine Vianey-Saban et al. J Inherit Metab Dis. 2023 Sep.

Abstract

Since the identification of the first disorder of mitochondrial fatty acid oxidation defects (FAOD) in 1973, more than 20 defects have been identified. Although there are some differences, most FAOD have similar clinical signs, which are mainly due to energy depletion and toxicity of accumulated metabolites. However, some of them have an unusual clinical phenotype or specific clinical signs. This manuscript focuses on what we have learnt so far on the pathophysiology of these disorders, which present with clinical signs that are not typical of categorical FAOD. It also highlights that some disorders have not yet been identified and tries to make assumptions to explain why. It also deals with new treatments under consideration in FAOD, including triheptanoin and similar anaplerotic substrates, ketone body treatments, RNA and gene therapy approaches. Finally, it suggests challenges for the diagnosis of FAOD in the coming years, both for symptomatic patients and for those diagnosed through newborn screening. The ultimate goal would be to identify all the patients born with FAOD and ensure for them the best possible quality of life.

Keywords: inborn errors of riboflavin metabolism; mitochondrial fatty acid oxidation disorders.

PubMed Disclaimer

References

REFERENCES

    1. DiMauro S, DiMauro PM. Muscle carnitine palmityltransferase deficiency and myoglobinuria. Science. 1973;182(4115):929-931. doi:10.1126/science.182.4115.929
    1. Karpati G, Carpenter S, Engel AG, et al. The syndrome of systemic carnitine deficiency. Clinical, morphologic, biochemical, and pathophysiologic features. Neurology. 1975;25(1):16-24. doi:10.1212/wnl.25.1.16
    1. Mosegaard S, Bruun GH, Flyvbjerg KF, et al. An intronic variation in SLC52A1 causes exon skipping and transient riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency. Mol Genet Metab. 2017;122(4):182-188. doi:10.1016/j.ymgme.2017.10.014
    1. Przyrembel H, Wendel U, Becker K, et al. Glutaric aciduria type II: report on a previously undescribed metabolic disorder. Clin Chim Acta. 1976;66(2):227-239. doi:10.1016/0009-8981(76)90060-7
    1. Bougnères PF, Saudubray JM, Marsac C, Bernard O, Odièvre M, Girard J. Fasting hypoglycemia resulting from hepatic carnitine palmitoyl transferase deficiency. J Pediatr. 1981;98(5):742-746. doi:10.1016/s0022-3476(81)80834-7

MeSH terms

LinkOut - more resources